Viewing Study NCT02484833


Ignite Creation Date: 2025-12-25 @ 2:48 AM
Ignite Modification Date: 2026-02-12 @ 4:32 AM
Study NCT ID: NCT02484833
Status: COMPLETED
Last Update Posted: 2020-03-31
First Post: 2015-04-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Erbitux MEtastatic Colorectal Cancer Strategy Study
Sponsor: Armando Orlandi
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Antineoplastic Agents View
Keywords:

Keywords

Keyword Brief Keyword Text View
None First line View
None metastatic colorectal cancer View
None Cetuximab View
None strategy study View